AIMS/HYPOTHESIS: The enzyme hormone-sensitive lipase (HSL) is produced and is active in pancreatic beta cells. Because lipids are known to play a crucial role in normal control of insulin release and in the deterioration of beta cell function, as observed in type 2 diabetes, actions of HSL in beta cells may be critical. This notion has been addressed in different lines of HSL knockout mice with contradictory results. METHODS: To resolve this, we created a transgenic mouse lacking HSL specifically in beta cells, and characterised this model with regard to glucose metabolism and insulin secretion, using both in vivo and in vitro methods. RESULTS: We found that fasting basal plasma glucose levels were significantly elevated in mice lacking HSL in beta cells. An IVGTT at 12 weeks revealed a blunting of the initial insulin response to glucose with delayed elimination of the sugar. Additionally, arginine-stimulated insulin secretion was markedly diminished in vivo. Investigation of the exocytotic response in single HSL-deficient beta cells showed an impaired response to depolarisation of the plasma membrane. Beta cell mass and islet insulin content were increased, suggesting a compensatory mechanism, by which beta cells lacking HSL strive to maintain normoglycaemia. CONCLUSIONS/ INTERPRETATION: Based on these results, we suggest that HSL, which is located in close proximity of the secretory granules, may serve as provider of a lipid-derived signal essential for normal insulin secretion.
AIMS/HYPOTHESIS: The enzyme hormone-sensitive lipase (HSL) is produced and is active in pancreatic beta cells. Because lipids are known to play a crucial role in normal control of insulin release and in the deterioration of beta cell function, as observed in type 2 diabetes, actions of HSL in beta cells may be critical. This notion has been addressed in different lines of HSL knockout mice with contradictory results. METHODS: To resolve this, we created a transgenic mouse lacking HSL specifically in beta cells, and characterised this model with regard to glucose metabolism and insulin secretion, using both in vivo and in vitro methods. RESULTS: We found that fasting basal plasma glucose levels were significantly elevated in mice lacking HSL in beta cells. An IVGTT at 12 weeks revealed a blunting of the initial insulin response to glucose with delayed elimination of the sugar. Additionally, arginine-stimulated insulin secretion was markedly diminished in vivo. Investigation of the exocytotic response in single HSL-deficient beta cells showed an impaired response to depolarisation of the plasma membrane. Beta cell mass and islet insulin content were increased, suggesting a compensatory mechanism, by which beta cells lacking HSL strive to maintain normoglycaemia. CONCLUSIONS/ INTERPRETATION: Based on these results, we suggest that HSL, which is located in close proximity of the secretory granules, may serve as provider of a lipid-derived signal essential for normal insulin secretion.
Authors: Guenter Haemmerle; Robert Zimmermann; Marianne Hayn; Christian Theussl; Georg Waeg; Elke Wagner; Wolfgang Sattler; Thomas M Magin; Erwin F Wagner; Rudolf Zechner Journal: J Biol Chem Date: 2001-11-20 Impact factor: 5.157
Authors: Miriam Cnop; Melinda J Landchild; Josep Vidal; Peter J Havel; Negar G Knowles; Darcy R Carr; Feng Wang; Rebecca L Hull; Edward J Boyko; Barbara M Retzlaff; Carolyn E Walden; Robert H Knopp; Steven E Kahn Journal: Diabetes Date: 2002-04 Impact factor: 9.461
Authors: Shu Pei Wang; Shari Chung; Krishnakant Soni; Hugo Bourdages; Louis Hermo; Jacquetta Trasler; Grant A Mitchell Journal: Endocrinology Date: 2004-09-02 Impact factor: 4.736
Authors: Patrick M McDonough; Randall S Ingermanson; Patricia A Loy; Erick D Koon; Ross Whittaker; Casey A Laris; Jeffrey M Hilton; James B Nicoll; Benjamin M Buehrer; Jeffrey H Price Journal: Assay Drug Dev Technol Date: 2010-12-27 Impact factor: 1.738
Authors: Petr Ježek; Blanka Holendová; Martin Jabůrek; Jan Tauber; Andrea Dlasková; Lydie Plecitá-Hlavatá Journal: Antioxidants (Basel) Date: 2021-01-29
Authors: Jay V Patankar; Prakash G Chandak; Sascha Obrowsky; Thomas Pfeifer; Clemens Diwoky; Andreas Uellen; Wolfgang Sattler; Rudolf Stollberger; Gerald Hoefler; Akos Heinemann; Michele Battle; Stephen Duncan; Dagmar Kratky; Sanja Levak-Frank Journal: Am J Physiol Endocrinol Metab Date: 2010-12-21 Impact factor: 4.310
Authors: Jose Iglesias; Julien Lamontagne; Heidi Erb; Sari Gezzar; Shangang Zhao; Erik Joly; Vouy Linh Truong; Kathryn Skorey; Sheldon Crane; S R Murthy Madiraju; Marc Prentki Journal: J Lipid Res Date: 2015-09-30 Impact factor: 5.922
Authors: Marie-Line Peyot; Claudiane Guay; Martin G Latour; Julien Lamontagne; Roxane Lussier; Marco Pineda; Neil B Ruderman; Guenter Haemmerle; Rudolf Zechner; Erik Joly; S R Murthy Madiraju; Vincent Poitout; Marc Prentki Journal: J Biol Chem Date: 2009-04-22 Impact factor: 5.157
Authors: James Cantley; James G Burchfield; Gemma L Pearson; Carsten Schmitz-Peiffer; Michael Leitges; Trevor J Biden Journal: Diabetes Date: 2009-04-28 Impact factor: 9.461